Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
05/09/20198:56AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/09/20198:53AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/08/20194:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/08/20194:01PMPR Newswire (US)AcelRx Pharmaceuticals Reports First Quarter 2019 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/03/20195:06PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/30/20196:34AMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/25/20194:05PMPR Newswire (US)AcelRx to announce first quarter 2019 results and provide an update on the company's business on Wednesday, May 8th, 2019NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/11/20194:37PMPR Newswire (US)AcelRx Pharmaceutical's pooled safety results for sufentanil sublingual tablets (DSUVIA) selected for presentation at 44th An...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/12/20192:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/11/20194:01PMPR Newswire (US)AcelRx Pharmaceuticals to Present at Oppenheimer & Co. Inc. 29th Annual Healthcare ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/07/20195:58PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/07/20195:58PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/07/20194:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/07/20194:01PMPR Newswire (US)AcelRx Pharmaceuticals Announces Commercial Launch of DSUVIA and Reports Fourth Quarter and Full Year 2018 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/04/20194:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/04/20194:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/04/20194:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/04/20194:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/04/20194:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/22/20199:25AMPR Newswire (US)AcelRx to announce fourth quarter 2018 results and provide a corporate update on Thursday, March 7th, 2019NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/14/20196:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/13/20195:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/13/20195:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/13/20195:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/13/20195:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/13/20195:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/07/20195:35PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/31/20197:00AMPR Newswire (US)AcelRx Pharmaceutical's sufentanil sublingual tablet (DSUVIA) to be highlighted during a presentation at the Boswick Burn and...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/11/20194:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/07/20198:30AMPR Newswire (US)AcelRx Pharmaceuticals announces publication analyzing pooled data on sufentanil sublingual tablets for short-term treatment ...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX